Skip to content

Intervention study by pharmacy pharmacist to prevent flail

Effects of Flail Prophylaxis Interventions by The Health Support Pharmacy Pharmacists on aged Chronic Disease Patients : a Practical Cluster Randomized Trial - FHSP Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042571
Enrollment
120
Registered
2021-01-01
Start date
2020-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flail

Interventions

At the time of medication instruction, you will be given a leaflet of &quot
Exercise to prevent flail at home&quot
(Attachment 4) to prevent flail, and encourage daily exercise and exercise to prevent flail. At the time of the 2nd to 5th visits to the station, we will give you the flail prevention exercise leaflet
five chair stand-up test&quot
and record it. After the 6th visit (final) medication instruction, measure &quot
muscle mass&quot
weight&quot
body fat percentage&quot
BMI&quot
estimated bone mass&quot
5th chair standing test&quot
with a body composition analyzer, and &quot
record&quot
Record on &quot
paper&quot

Sponsors

General Incorporated Association Osaka Pharmaplan Aozora Pharmacy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Of the 12 pharmacies operated by Osaka Pharma Plan, 10 pharmacies that meet the standards of health support pharmacies (Aozora Pharmacy, Aozora Pharmacy Awaji Store, Aoba Pharmacy, Kagayaki Pharmacy, Kotsuma Pharmacy, Sumire Pharmacy, Soyokaze Pharmacy, Nagisa Pharmacy, Natsume Pharmacy, Moegi Pharmacy), among the patients who come to the pharmacy to receive prescription dispensing every month, are prescribed for chronic diseases (hypertension, diabetes, dyslipidemia, etc.) 75 years old to 79 years old Among the following patients, those who consented to this study are the target patients.

Exclusion criteria

Exclusion criteria: Patients who are undergoing treatment that may affect physical malnutrition or bones, such as cancer patients. Patients who are prescribed an osteoporosis drug. Patients who are prescribed antidepressants or antipsychotics. Patients who are prescribed steroids. Patients who are prescribed dementia medication. Obese patients with a BMI of 30% or higher. Patients receiving exercise restriction guidance from their doctor.

Design outcomes

Primary

MeasureTime frame
The amount of change(Kg) and the rate of change(%) of "muscle mass by site" measured with a body composition analyzer after 6 months. The rate of change(%) after 6 months of the "5 times chair stand-up test".

Secondary

MeasureTime frame
The amount and rate of change of "body weight," "body fat percentage," "BMI," and "estimated bone mass" measured with a body composition analyzer after 6 months. Comparison between groups of the results of the "health status questionnaire" that was first surveyed and comparison of the amount of change in body composition. Evaluation of the results of the "retrospective questionnaire" surveyed 6 months later.

Countries

Japan

Contacts

Public ContactNoritake Hirota

General Incorporated Association Osaka Pharmaplan Aozora Pharmacy

n-hirota@faruma.co.jp0664778088

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026